There was a significant decrease (p<0.05, Figure 5A) in GFAP+ cells in the peri-infarct area in the rGDF11 treated mice compared to vehicle-treated stroke mice, reflecting reduced astrogliosis after exogenous rGDF11 treatment. The gene discussed is GFAP; the disease is stroke disorder.